# Mature hiPSC-CM Ionic Models — Idea Log

> Thinking trail: how our understanding evolved, what we tried, what failed.
> Scan this in 30 seconds to remember where we are and how we got here.
> Not promoted on completion — archived for historical record.

## Current Direction
Core maturation pathway complete: PHAS13 (immature, spontaneous) -> MHAS13 (matured, quiescent) via IK1 injection at Verkerk 2019 critical conductance + If suppression (g_f=0). Single-cell and bidomain tissue validation both pass (APD=349ms, CV=15.8cm/s, V_rest=-83.7mV). Two items remain: an ORd-based mature hiPSC variant (alternative maturation pathway) and restitution curve characterization.

## Next Step
Implement ORd-based mature hiPSC variant as an alternative maturation pathway, or characterize MHAS13 restitution curves at multiple pacing rates. Both are listed as incomplete in completion criteria.

## Thread

### 2026-03-17: Maturation pathway validated through bidomain pipeline
MHAS13 was run through the full Bidomain V1 pipeline, confirming tissue-level behavior: APD=349ms, CV=15.8cm/s. This validates that the IK1 injection + If suppression approach produces a quiescent model that propagates correctly in tissue, not just in single-cell isolation. The model serves as the primary ionic model for optimization work (Optimizer V1) and as a negative control for geometry-induced pacemaking experiments (where PHAS13's spontaneous beating is required).

### 2026-03-17: Three-document architecture adopted
As part of the research environment optimization, this question's folder now follows the KNOWLEDGE + IDEALOG + PLAN structure. IDEALOG captures the thinking trail; KNOWLEDGE (when created) will hold reference facts and analysis.

## Failed Approaches
*No failed approaches recorded yet — the IK1 injection + If suppression pathway succeeded on the first approach.*

## Session Log

Pre-IDEALOG history — thinking trail started 2026-03-17.
